Investment Stage – Growth Round
Inotec, now NATROX® Oxygen Wound Therapy is an FDA cleared and CE marked simple device for the treatment of chronic hard to heal wounds.
Spex Capital Ltd. (SPEX), registered in England and Wales, is authorised and regulated by the Financial Conduct Authority having Firm Reference Number 963796.
©2023 · Spex Capital
©2022 · Spex Capital